Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Megna Michael R Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 4 Megna Michael R (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Paid exercise price by delivering 52 shares @ $16.01, valued at $832.5
Exercised 175 options to buy @ $0
04/03/2023 4 Megna Michael R (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 20,459 options to buy @ $10.76, valued at $220.1k
Granted 10,230 options to buy @ $0
03/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/06/2022 4 Megna Michael R (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 703 shares @ $9.56, valued at $6.7k
Paid exercise price by delivering 228 shares @ $11.44, valued at $2.6k
Granted 31,460 options to buy @ $11.97, valued at $376.6k
Granted 15,730 options to buy @ $0
Exercised 775 options to buy @ $0
04/11/2022 4 Megna Michael R (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 31,460 options to buy @ $11.1, valued at $349.2k
Granted 15,730 options to buy @ $0
03/23/2022 4 Megna Michael R (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Paid exercise price by delivering 1,120 shares @ $10.98, valued at $12.3k
Exercised 3,231 options to buy @ $0
03/18/2022 4 Megna Michael R (Chief Accounting Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 641 shares @ $9.51, valued at $6.1k
Granted 405 shares @ $15.02, valued at $6.1k
Granted 588 shares @ $11.49, valued at $6.8k
Granted 653 shares @ $9.63, valued at $6.3k
Paid exercise price by delivering 269 shares @ $10.13, valued at $2.7k
Exercised 775 options to buy @ $0
10/06/2021 4 Megna Michael R (Chief Accounting Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 700 options to buy @ $0
09/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/14/2020 4 Megna Michael R (Chief Accounting Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 19,000 options to buy @ $15.5, valued at $294.5k
03/17/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/10/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
02/26/2010 4 Megna Michael R (Chief Accounting Officer) has filed a Form 4 on BIOSPHERE MEDICAL INC
Txns: Granted 18,600 shares @ $0.01, valued at $186

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy